BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 10761961)

  • 21. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
    Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.
    Tan NC; Venketasubramanian N; Saw SM; Tjia HT
    Stroke; 2002 Aug; 33(8):1956-62. PubMed ID: 12154245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.
    Falcon CR; Cattaneo M; Panzeri D; Martinelli I; Mannucci PM
    Arterioscler Thromb; 1994 Jul; 14(7):1080-3. PubMed ID: 8018663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
    Beaumont V; Malinow MR; Sexton G; Wilson D; Lemort N; Upson B; Beaumont JL
    Atherosclerosis; 1992 Jun; 94(2-3):147-52. PubMed ID: 1632868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
    Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
    Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC; Stanger O
    Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
    Sydow K; Böger RH
    Z Kardiol; 2001 Jan; 90(1):1-11. PubMed ID: 11220081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
    Stanger O; Weger M; Renner W; Konetschny R
    Clin Chem Lab Med; 2001 Aug; 39(8):725-33. PubMed ID: 11592442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?
    Virdis A; Ghiadoni L; Versari D; Salvetti G; Pinto S; Favilla S; Taddei S; Salvetti A
    Curr Pharm Des; 2005; 11(17):2187-97. PubMed ID: 16026288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.
    Eikelboom JW; Lonn E; Genest J; Hankey G; Yusuf S
    Ann Intern Med; 1999 Sep; 131(5):363-75. PubMed ID: 10475890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homocysteine as a novel risk factor for atherosclerosis.
    Guthikonda S; Haynes WG
    Curr Opin Cardiol; 1999 Jul; 14(4):283-91. PubMed ID: 10448607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
    Moghadasian MH; McManus BM; Frohlich JJ
    Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
    Kang SS; Wong PW
    Atherosclerosis; 1996 Jan; 119(2):135-8. PubMed ID: 8808490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes and consequences of hyperhomocyst(e)inemia.
    Pietrzik K; Brönstrup A
    Int J Vitam Nutr Res; 1997; 67(5):389-95. PubMed ID: 9350483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
    Lalouschek W; Aull S; Deecke L; Schnider P; Uhl F; Zeiler K
    Fortschr Neurol Psychiatr; 1996 Jul; 64(7):271-7. PubMed ID: 8765893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease.
    Parnetti L; Caso V; Amici S; Lanari A; Gallai V; Bottiglieri T
    Clin Exp Hypertens; 2002; 24(7-8):501-9. PubMed ID: 12450225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension?
    Virdis A; Ghiadoni L; Salvetti G; Versari D; Taddei S; Salvett A
    J Nephrol; 2002; 15(4):414-21. PubMed ID: 12243373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia.
    Ubbink JB
    J Inherit Metab Dis; 1997 Jun; 20(2):316-25. PubMed ID: 9211204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between homocyst(e)ine levels and risk of vascular events.
    Kaplan ED
    Drugs Today (Barc); 2003 Mar; 39(3):175-92. PubMed ID: 12730702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.